Search Result

Results for "

racemic mixture

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5 alpha Reductase (1) Apoptosis (1) Bacterial (1) Biochemical Assay Reagents (1) CDK (1) Cytochrome P450 (1) Endogenous Metabolite (2) Enolase (1) Fungal (2) Histone Methyltransferase (1) Isotope-Labeled Compounds (4) Mitochondrial Metabolism (1) nAChR (1) Parasite (1) PPAR (1) RSV (1) Topoisomerase (2) TRP Channel (1)
By Research Areas:	Cancer (7) Cardiovascular Disease (1) Endocrinology (1) Infection (5) Inflammation/Immunology (3) Metabolic Disease (10) Neurological Disease (2)

Inhibitors & Agonists

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-100869B

*MM-589 (racemic* mixture ) (TFA)**	Histone Methyltransferase	Cancer
MM-589 (racemic mixture) TFA, is a racemic mixture of MM-589 TFA (HY-100869A). MM-589 TFA is a potent inhibitor of WD repeat domain 5 (WDR5) and mixed lineage leukemia (MLL) protein-protein interaction. MM-589 binds to WDR5 with an IC₅₀ of 0.90 nM and inhibits the MLL H3K4 methyltransferase activity with an IC₅₀ of 12.7 nM .

HY-145263A

VD2173 epimer-1

Others Cancer

VD2173 epimer-1 is a racemic mixture of VD2173 (HY-145263) .

VD2173 epimer-1	Others	Cancer
VD2173 epimer-1 is a racemic mixture of VD2173 (HY-145263) .

HY-110406A

(±)13-HpODE 13-Hydroperoxylinoleic acid; Linoleic acid 13-hydroperoxide	Others	Others
(±)13-HpODE (13-hydroperoxylinoleic acid) is a racemic mixture of hydroperoxides, which is produced by the oxidation of linoleic acid by lipoxygenase .

HY-120109

13-HODE methyl ester	Endogenous Metabolite	Cancer
13-HODE methyl ester, a racemic mixture of 13(R)-HODE methyl ester and 13(S)-HODE methyl ester, is a 15-lipoxygenase metabolite of Linoleic acid .

HY-118590A

ICRF-196	Topoisomerase	Cancer
ICRF-196 is an racemic mixture of the (S,S)- and (R,R)-isomers of ICRF-193 (HY-118590). ICRF-193 is an TopoII inhibitor. ICRF-196 can be used for the research of cancer .

HY-118590

ICRF-193	Topoisomerase	Cancer
ICRF-193 is an TopoII inhibitor. (S,S)- and (R,R)-isomers ICRF-193 make up an racemic mixture, ICRF-196 (HY-118590A). ICRF-196 can be used for the research of cancer .

HY-130319A

9-HEPE	PPAR	Cardiovascular Disease Metabolic Disease
9-HEPE, a oxidation product of Eicosapentaenoic acid, is a racemic mixture of 9(R)-HEPE and 9(S)-HEPE. 9-HEPE induces fatty acid oxidation, adipogenesis, and glucose uptake via activation of PPARs in vivo .

HY-116663

(±)20-HDHA (±)20-HDoHE	Endogenous Metabolite	Neurological Disease
(±)20-HDHA ((±)20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA). (±)20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate .

HY-Y1315

DL-Tartaric acid

1 Publications Verification

Others Others

DL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acids with antioxidant activities .

DL-Tartaric acid 1 Publications Verification	Others	Others
DL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acids with antioxidant activities .

HY-B0399A

DL-Carnitine (±)-Carnitin	Mitochondrial Metabolism	Metabolic Disease
DL-Carnitine is a racemic mixture of L-Carnitine and D-Carnitine, regulates fatty acid transport in mitochondria, elevates serum carnitine fractions.

HY-B2236

DL-Lysine (±)-2,6-Diaminocaproic acid	Others	Metabolic Disease
DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins .

HY-B2236A

DL-Lysine monohydrate (±)-2,6-Diaminocaproic acid monohydrate	Others	Metabolic Disease
DL-Lysine monohydrate is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins .

HY-134818

ML-SI1

4 Publications Verification

TRP Channel Neurological Disease

ML-SI1, a racemic mixture of diastereomers, is a TRPML inhibitor with an IC₅₀ value of 15 μM for TRPML1 .
HY-12993A

RSV604 racemate

A-60444 racemate
RSV Others

RSV604 (A-60444) racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer.

ML-SI1 4 Publications Verification	TRP Channel	Neurological Disease
ML-SI1, a racemic mixture of diastereomers, is a TRPML inhibitor with an IC₅₀ value of 15 μM for TRPML1 .

RSV604 racemate A-60444 racemate	RSV	Others
RSV604 (A-60444) racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer.

HY-103019A

(±)-Enitociclib (±)-BAY-1251152; (±)-VIP152	CDK	Cancer
(±)-Enitociclib ((±)-BAY-1251152) is a racemic mixture of BAY-1251152. BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

HY-Y1315R

DL-Tartaric acid (Standard)	Others	Others
DL-Tartaric acid (Standard) is the analytical standard of DL-Tartaric acid. This product is intended for research and analytical applications. DL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acids with antioxidant activities .

HY-B0105B

(-)-Ketoconazole (-)-Ketoconazol; (-)-R 41400	Fungal	Infection Inflammation/Immunology
(-)-Ketoconazole ((-)-R 41400) is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

HY-B2236S

DL-Lysine-d4 dihydrochloride (±)-2,6-Diaminocaproic acid-d₄ dihydrochloride	Isotope-Labeled Compounds	Metabolic Disease
DL-Lysine-4,4,5,5-d₄ (dihydrochloride) is the deuterium labeled DL-Lysine. DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins[1].

HY-B0105BS

(-)-Ketoconazole-d3 (-)-Ketoconazol-d₃; (-)-R 41400-d₃	Fungal	Infection Inflammation/Immunology
(-)-Ketoconazole-d₃ is deuterium labeled (-)-Ketoconazole. (-)-Ketoconazole ((-)-R 41400) is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

HY-B2236S3

DL-Lysine-15N2 hydrochloride (±)-2,6-Diaminocaproic acid-¹⁵N₂ hydrochloride	Isotope-Labeled Compounds	Metabolic Disease
DL-Lysine- ¹⁵N₂ hydrochloride ((±)-2,6-Diaminocaproic acid- ¹⁵N₂ hydrochloride) is ¹⁵N labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.

HY-B2236S1

DL-Lysine-13C6 hydrochloride (±)-2,6-Diaminocaproic acid-¹³C₆ hydrochloride	Isotope-Labeled Compounds	Metabolic Disease
DL-Lysine- ¹³C₆ hydrochloride ((±)-2,6-Diaminocaproic acid- ¹³C₆ hydrochloride) is ¹³C-labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.

HY-118091

LY191704	5 alpha Reductase	Endocrinology
LY191704, as a benzoquinolinone, is a potent, nonsteroidal, noncompetitive and selective human type I 5α-reductase inhibitor. LY191704 is a racemic mixture of the compounds LY300502 and LY300503. LY191704 may be useful in the research of human endocrine disorders associated with overproduction of dihydrotestosterone (DHT) by 5α-reductase type 1 .

HY-P2834

Penicillin amidase, E. coli PGA	Biochemical Assay Reagents	Infection
Penicillin amidase (EC 3.5.1.11) (Penicillin acylase) is an enzyme that cleaves the acyl side chains of penicillins. Penicillin amidase can be used for the production of 6-aminopenicillanic acid. Penicillin amidase can also be used in the resolution of racemic mixtures, peptide synthesis, and synthesis of semi-synthetic β-lactam antibiotics .

HY-B0827A

(R)-Dinotefuran (R)-MTI-446	nAChR Parasite	Infection
(R)-Dinotefuran ((R)-MTI-446), a neonicotinoid pesticide, exhibits comparative insecticidal activities (1.7-2.4 times) to typical sucking pests Aphis gossypii and Apolygus lucorum compared to racemic mixtures by inhibiting nicotinic acetylcholine receptors. (R)-Dinotefuran has a good efficacy in controlling target pests while minimizing hazard to honeybees .

HY-131904

POMHEX 1 Publications Verification	Enolase Apoptosis	Metabolic Disease Cancer
POMHEX, a racemic mixture and a cell-permeable pivaloyloxymethyl (POM) proagent of HEX, is a potent, ENO2-specific inhibitor of enolase. POMHEX exhibits low-nanomolar potency against ENO1-deleted cells in vitro and is capable of eradicating ENO1-deleted xenografted tumours in vivo. POMHEX is a potent glycolysis inhibitor .

HY-137258

(±)-N-3-Benzylnirvanol	Cytochrome P450	Metabolic Disease
(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. (+)-N-3-Benzylnirvanol and (–)-N-3-Benzylnirvanol are potent and selective cytochrome P450 inhibitors with K_i values of 0.25 and 5.3 μM for CYP2C19, respectively .

HY-B2236S2

DL-Lysine-13C6,15N2 hydrochloride (±)-2,6-Diaminocaproic acid-¹³C₆,¹⁵N₂ hydrochloride	Isotope-Labeled Compounds	Metabolic Disease
DL-Lysine- ¹³C₆, ¹⁵N₂ hydrochloride ((±)-2,6-Diaminocaproic acid- ¹³C₆, ¹⁵N₂ hydrochloride) is ¹³C and ¹⁵N-labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.

HY-113764

N-Butanoyl-DL-homoserine lactone (Rac)-C4-HSL	Bacterial	Infection Inflammation/Immunology
N-Butanoyl-DL-homoserine lactone ((Rac)-C4-HSL) is a racemic mixture of N-Butanoyl-D-homoserine lactone and N-Butanoyl-L-homoserine lactone. N-Butanoyl-L-homoserine lactone is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Butanoyl-L-homoserine lactone has antibacterial activity and is used in antibacterial biofilm. N-Butanoyl-L-homoserine lactone aptamers blocks qurom sensing and inhibits biofilm formation in Pseudomonas aeruginosa .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-116663

(±)20-HDHA (±)20-HDoHE	Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Endogenous Metabolite
(±)20-HDHA ((±)20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA). (±)20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate .

HY-B2236

DL-Lysine (±)-2,6-Diaminocaproic acid	Classification of Application Fields Source classification Metabolic Disease Amino acids Endogenous metabolite Disease Research Fields	Others
DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins .

HY-120109

13-HODE methyl ester	Structural Classification Natural Products Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Cancer	Endogenous Metabolite
13-HODE methyl ester, a racemic mixture of 13(R)-HODE methyl ester and 13(S)-HODE methyl ester, is a 15-lipoxygenase metabolite of Linoleic acid .

HY-B0399A

DL-Carnitine (±)-Carnitin	Structural Classification Natural Products Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Mitochondrial Metabolism
DL-Carnitine is a racemic mixture of L-Carnitine and D-Carnitine, regulates fatty acid transport in mitochondria, elevates serum carnitine fractions.

Cat. No.	Product Name	Chemical Structure

HY-B2236S

DL-Lysine-d4 dihydrochloride
DL-Lysine-4,4,5,5-d₄ (dihydrochloride) is the deuterium labeled DL-Lysine. DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins[1].

HY-B0105BS

(-)-Ketoconazole-d3
(-)-Ketoconazole-d₃ is deuterium labeled (-)-Ketoconazole. (-)-Ketoconazole ((-)-R 41400) is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(−)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).

HY-B2236S3

DL-Lysine-15N2 hydrochloride
DL-Lysine- ¹⁵N₂ hydrochloride ((±)-2,6-Diaminocaproic acid- ¹⁵N₂ hydrochloride) is ¹⁵N labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.

HY-B2236S1

DL-Lysine-13C6 hydrochloride
DL-Lysine- ¹³C₆ hydrochloride ((±)-2,6-Diaminocaproic acid- ¹³C₆ hydrochloride) is ¹³C-labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.

HY-B2236S2

DL-Lysine-13C6,15N2 hydrochloride
DL-Lysine- ¹³C₆, ¹⁵N₂ hydrochloride ((±)-2,6-Diaminocaproic acid- ¹³C₆, ¹⁵N₂ hydrochloride) is ¹³C and ¹⁵N-labeled DL-Lysine (HY-B2236). DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

racemic mixture

Inhibitors & Agonists

NaturalProducts

Isotope-Labeled Compounds

Natural
Products